Entire Transcript in Adobe Acrobat Format - National Reference ...

137
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
MS. BARR: We made the assumption it was cancer
generally. That was what our language was.
DR. EMANUEL: But if I turn out to have a
negative biopsy, you know, what I have consented to then if
you say can be used for similar diseases. Is it cancer or
not or is it just benign breast diseases?
You have already made certain assumptions that
someone who goes in for a breast biopsy you are going to
put them in the cancer classification even though if it is
negative for them they might have gone far away from the
cancer classification and they are now normal. Similarly
for many other conditions.
I think again the issue is not purely an
informatics and money issue. The issue also is we may feel
in our ideal notions of what informed consent does that the
more we delineate the bigger that piece of paper is the
better the consent.
My suggestion is the more layers you have we,
as ethicists, may feel more comfortable but, in fact, the
process may be inhibited. What we need to concentrate on
is not have we given 12 boxes as opposed to two boxes but
do the people out there have a reasonable sense even if we
have not included all the specifics and that is why I -- my
own view is not because of the informatics necessarily and